AstraZeneca to Buy Gracell Biotechnologies
Wall Street Journal
AstraZeneca has agreed to buy Gracell Biotechnologies for a transaction value of $1.2 billion, as part of the former’s efforts to grow its cell therapies business.
https://www.wsj.com/articles/astrazeneca-to-buy-gracell-biotechnologies-for-1-2-billion-32f66fbd